Is Endometriosis Genetic? Hereditary Risk and DNA Factors

It takes an average of 7 to 9 years to get an endometriosis diagnosis (Agarwal et al., 2019). During that time, millions of women cycle through emergency rooms, dismissed symptoms, and trial-and-error treatments -- all while a condition with a strong genetic component goes unrecognized.

Yes, endometriosis has a significant genetic basis. Twin studies estimate that roughly 51% of the variation in endometriosis risk comes from genetic factors (Treloar et al., 1999). If your mother, sister, or daughter has endometriosis, your own risk is 7 to 10 times higher than someone without that family history (Simpson et al., 1981). That does not mean endometriosis is inevitable if it runs in your family, but it does mean your DNA plays a central role in whether you develop it -- and understanding that role could shorten the agonizing path to diagnosis.

What Is Endometriosis?

Endometriosis is a chronic condition where tissue similar to the uterine lining grows outside the uterus -- on the ovaries, fallopian tubes, bowel, bladder, and other pelvic structures. This displaced tissue responds to hormonal cycles just like the endometrium inside the uterus, leading to inflammation, scarring, and adhesions.

The condition affects approximately 10% of women of reproductive age worldwide, translating to roughly 190 million people (Zondervan et al., 2020). Common symptoms include:

• Severe pelvic pain, especially during menstruation (dysmenorrhea)
• Pain during intercourse (dyspareunia)
• Chronic pelvic pain unrelated to periods
• Heavy or irregular bleeding
• Infertility -- endometriosis is found in 30-50% of women struggling to conceive (Giudice & Kao, 2004)
• Fatigue, bloating, and gastrointestinal symptoms

Despite its prevalence, endometriosis remains chronically underdiagnosed. Definitive diagnosis historically required surgery (laparoscopy), though imaging techniques are improving. The average diagnostic delay of 7 to 11 years means most patients endure nearly a decade of symptoms before getting answers (Hudelist et al., 2012).

The Heritability of Endometriosis: What Twin Studies Reveal

The strongest evidence for a genetic basis comes from twin research. A landmark Australian study of 3,096 twins found that genetic factors account for 51% of the liability for developing endometriosis (Treloar et al., 1999). In that study, 2% of identical (monozygotic) twin pairs were concordant for the disease, compared to just 0.6% of fraternal (dizygotic) pairs -- a pattern consistent with significant genetic influence.

A follow-up analysis using the Swedish Twin Registry confirmed these findings, estimating heritability at approximately 47-52% (Saha et al., 2015). To put that in perspective, endometriosis is about as heritable as type 2 diabetes and more heritable than many common conditions people think of as "genetic."

Family studies tell a similar story. Simpson and colleagues first demonstrated a seven-fold increased risk of endometriosis in first-degree relatives of affected women compared to the general population (Simpson et al., 1981). More recent analyses suggest the risk increase may be as high as 10-fold for sisters and mothers of patients (Stefansson et al., 2002).

What this means in practical terms: if endometriosis runs in your family, your baseline risk is not the population average of 10%. It is substantially higher, and that information should shape how aggressively you and your doctor investigate pelvic symptoms.

Key Genes and Genomic Regions Linked to Endometriosis

Endometriosis is polygenic -- no single gene causes it. Instead, dozens of common genetic variants each contribute a small amount of risk. Genome-wide association studies (GWAS) have now identified 42 to 45 genomic loci significantly associated with the condition (Rahmioglu et al., 2023; FinnGen Consortium, 2024).

Here are the most well-replicated genes and regions:

• WNT4 (chromosome 1p36.12) -- One of the most consistently replicated endometriosis genes. WNT4 is critical for female reproductive tract development and hormone signaling. The risk allele of rs7521902 near WNT4 increases susceptibility with an odds ratio of approximately 1.20 (Nyholt et al., 2012). Variants at this locus also influence estrogen receptor binding, directly connecting genetic risk to the hormonal pathways driving the disease (Powell et al., 2024).

• GREB1 (chromosome 2p25.1) -- Encodes a protein regulated by estrogen that promotes cell growth. The SNP rs13394619 in GREB1 is genome-wide significant for endometriosis, with an odds ratio around 1.15 (Nyholt et al., 2012). This gene is also implicated in breast cancer, suggesting shared estrogen-driven pathways.

• VEZT (chromosome 12q22) -- Encodes vezatin, a cell adhesion protein. The variant rs10859871 near VEZT shows one of the strongest associations with endometriosis (OR = 1.20, P = 4.7 x 10^-15), and may influence how endometrial cells attach to surfaces outside the uterus (Nyholt et al., 2012).

• CDKN2B-AS1 (chromosome 9p21.3) -- This region is a known risk locus for multiple diseases including heart disease and type 2 diabetes. The variant rs1537377 is associated with endometriosis and may influence cell cycle regulation and tissue growth (Painter et al., 2011).

• FN1 (chromosome 2q35) -- Encodes fibronectin, a protein involved in cell adhesion and tissue remodeling. Variants in this region have been linked specifically to ovarian endometriosis (Rahmioglu et al., 2014).

• ESR1 (chromosome 6q25.1) -- The estrogen receptor alpha gene. Risk variants here overlap with breast cancer susceptibility loci, reinforcing the role of estrogen signaling in endometriosis pathology (Sapkota et al., 2017).

• IL1A (chromosome 2q13) -- Encodes interleukin-1 alpha, an inflammatory cytokine. This locus highlights the immune and inflammatory component of endometriosis risk (Sapkota et al., 2017).

How Genetics and Hormones Interact

The genetic architecture of endometriosis points overwhelmingly toward estrogen signaling and hormone metabolism as central disease mechanisms. Many of the identified risk loci -- WNT4, GREB1, ESR1 -- are directly involved in how cells respond to estrogen (Gallagher et al., 2022).

This makes biological sense. Endometriotic lesions are estrogen-dependent: they grow in response to estrogen and shrink when estrogen is suppressed (as with hormonal treatments like GnRH agonists). Women with endometriosis often show altered local estrogen production within lesions, creating a self-sustaining hormonal environment even when systemic estrogen levels are normal (Bulun et al., 2019).

Genetic variants likely influence endometriosis risk by subtly shifting how efficiently cells produce, respond to, and break down estrogen. A woman who inherits several risk alleles across these hormone-related genes may have endometrial cells that are slightly more responsive to estrogen, slightly more adhesive, and slightly more resistant to immune clearance -- a combination that tips the balance toward disease over time.

What You Can Do With This Information

Understanding the genetic basis of endometriosis has practical implications:

If endometriosis runs in your family:

• Do not dismiss pelvic pain as "normal periods." A family history of endometriosis significantly raises your risk, and early evaluation can prevent years of unnecessary suffering.
• Tell your gynecologist about affected relatives. This context can prompt earlier imaging, referral to a specialist, or consideration of laparoscopy.
• Track your symptoms carefully. Apps and pain diaries create a record that helps clinicians recognize endometriosis patterns.

If you have a DNA test:

• Check for variants in key genes like WNT4, GREB1, and VEZT. While no single SNP predicts endometriosis, a pattern of risk alleles across multiple loci can inform your overall susceptibility.
• Upload your raw DNA data to tools like GenomeInsight to explore your genetic profile across reproductive health markers.
• Polygenic risk scores for endometriosis are an active area of research and may become clinically useful as GWAS datasets grow (Rahmioglu et al., 2023).

For everyone:

• Advocate for faster diagnosis. The 7-to-11-year diagnostic delay is unacceptable, and part of closing that gap is understanding that endometriosis has a biological -- not just behavioral -- basis.
• Stay informed about emerging treatments. Genetic research is identifying drug targets in estrogen metabolism and inflammatory pathways that could lead to more precise therapies.
• Consider genetic testing for related conditions like BRCA-associated cancer risk, since some endometriosis risk loci overlap with breast and ovarian cancer susceptibility regions.

Key Takeaways

• Endometriosis is approximately 51% heritable, with genetic factors playing a role comparable to many well-known "genetic" diseases.
• Having a first-degree relative with endometriosis increases your risk 7 to 10 times over the general population.
• GWAS have identified 42+ genomic loci associated with endometriosis, with key genes including WNT4, GREB1, VEZT, and ESR1.
• Most risk genes cluster around estrogen signaling, cell adhesion, and inflammation -- the core biological pathways driving the disease.
• Family history and genetic data can support earlier diagnosis, potentially cutting years off the current 7-to-11-year average delay.
• Exploring your DNA data for reproductive health variants is a practical step toward understanding your personal risk profile.

Want to see what your DNA says about endometriosis risk and hundreds of other health traits? Upload your raw DNA data to GenomeInsight -- it's free, private, and processed entirely on your device. Or subscribe to our newsletter to stay updated on the latest genetics research.

References

Agarwal, S. K., Chapron, C., Giudice, L. C., Laufer, M. R., Leyland, N., Missmer, S. A., Singh, S. S., & Taylor, H. S. (2019). Clinical diagnosis of endometriosis: A call to action. American Journal of Obstetrics and Gynecology, 220(4), 354.e1-354.e12. https://doi.org/10.1016/j.ajog.2018.12.039

Bulun, S. E., Yilmaz, B. D., Sison, C., Miyazaki, K., Bernardi, L., Liu, S., Kober, A., Desai, P., Yin, P., Cheng, Y. H., Zhao, H., Marchese, M., Brodie, J., Pavone, M. E., Shozu, M., & Seo, S. K. (2019). Endometriosis. Endocrine Reviews, 40(4), 1048-1079. https://doi.org/10.1210/er.2018-00242

Gallagher, C. S., Mori, T., Lanber, B., & Bhagavath, B. (2022). Insights from genomic studies on the role of sex steroids in the aetiology of endometriosis. Reproduction and Fertility, 3(2), R35-R46. https://doi.org/10.1530/RAF-21-0078

Giudice, L. C., & Kao, L. C. (2004). Endometriosis. The Lancet, 364(9447), 1789-1799. https://doi.org/10.1016/S0140-6736(04)17403-5

Hudelist, G., Fritzer, N., Thomas, A., Niber, C., Oppelt, P., Haas, D., Tammaa, A., & Salzer, H. (2012). Diagnostic delay for endometriosis in Austria and Germany: Causes and possible consequences. Human Reproduction, 27(12), 3412-3416. https://doi.org/10.1093/humrep/des316

Nyholt, D. R., Low, S. K., Anderson, C. A., Painter, J. N., Uno, S., Morris, A. P., MacGregor, S., Gordon, S. D., Henders, A. K., Martin, N. G., Attia, J., Holliday, E. G., McEvoy, M., Scott, R. J., Kennedy, S. H., Treloar, S. A., Missmer, S. A., Adachi, S., Tanaka, K., ... Zondervan, K. T. (2012). Genome-wide association meta-analysis identifies new endometriosis risk loci. Nature Genetics, 44(12), 1355-1359. https://doi.org/10.1038/ng.2445

Painter, J. N., Anderson, C. A., Nyholt, D. R., Macgregor, S., Lin, J., Lee, S. H., Lambert, A., Zhao, Z. Z., Roseman, F., Guo, Q., Gordon, S. D., Wallace, L., Henders, A. K., Visscher, P. M., Kraft, P., Martin, N. G., Morris, A. P., Treloar, S. A., Kennedy, S. H., ... Zondervan, K. T. (2011). Genome-wide association study identifies a locus at 7p15.2 associated with endometriosis. Nature Genetics, 43(1), 51-54. https://doi.org/10.1038/ng.731

Powell, J. E., Fung, J. N., Sapkota, Y., Treloar, S. A., Martin, N. G., & Montgomery, G. W. (2024). A common allele increases endometrial Wnt4 expression, with antagonistic implications for pregnancy, reproductive cancers, and endometriosis. Nature Communications, 15, 975. https://doi.org/10.1038/s41467-024-45338-4

Rahmioglu, N., Nyholt, D. R., Morris, A. P., Missmer, S. A., Montgomery, G. W., & Zondervan, K. T. (2014). Genetic variants underlying risk of endometriosis: Insights from meta-analysis of eight genome-wide association and replication datasets. Human Reproduction Update, 20(5), 702-716. https://doi.org/10.1093/humupd/dmu015

Rahmioglu, N., Mortlock, S., Engmann, M., Nyholt, D. R., & Zondervan, K. T. (2023). New insights into the genetics of endometriosis. Nature Reviews Genetics, 24, 197-211. https://doi.org/10.1038/s41576-022-00553-7

Saha, R., Pettersson, H. J., Svedberg, P., Olovsson, M., Bergqvist, A., Marions, L., Tornvall, P., & Kuja-Halkola, R. (2015). Heritability of endometriosis. Fertility and Sterility, 104(4), 947-952. https://doi.org/10.1016/j.fertnstert.2015.06.035

Sapkota, Y., Steinthorsdottir, V., Morris, A. P., Fassbender, A., Rahmioglu, N., De Vivo, I., ... Zondervan, K. T. (2017). Meta-analysis identifies five novel loci associated with endometriosis highlighting key genes involved in hormone metabolism. Nature Communications, 8, 15539. https://doi.org/10.1038/ncomms15539

Simpson, J. L., Elias, S., Malinak, L. R., & Buttram, V. C. (1981). Heritable aspects of endometriosis. I. Genetic studies. American Journal of Obstetrics and Gynecology, 137(3), 327-331. https://doi.org/10.1016/0002-9378(80)90917-5

Stefansson, H., Geirsson, R. T., Steinthorsdottir, V., Jonsson, H., Manolescu, A., Kong, A., Ingadottir, G., Gulcher, J., & Stefansson, K. (2002). Genetic factors contribute to the risk of developing endometriosis. Human Reproduction, 17(3), 555-559. https://doi.org/10.1093/humrep/17.3.555

Treloar, S. A., O'Connor, D. T., O'Connor, V. M., & Martin, N. G. (1999). Genetic influences on endometriosis in an Australian twin sample. Fertility and Sterility, 71(4), 701-710. https://doi.org/10.1016/S0015-0282(98)00540-8

Zondervan, K. T., Becker, C. M., & Missmer, S. A. (2020). Endometriosis. The New England Journal of Medicine, 382(13), 1244-1256. https://doi.org/10.1056/NEJMra1810764